BDMD (Baird Medical Investment Holdings) Total Payout Ratio : 0.00 (As of Apr. 30, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Baird Medical Investment Holdings's current Total Payout Ratio is 0.00.

Baird Medical Investment Holdings Total Payout Ratio Historical Data

The historical data trend for Baird Medical Investment Holdings's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Total Payout Ratio Chart

Baird Medical Investment Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Total Payout Ratio

0.53

Baird Medical Investment Holdings Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
Total Payout Ratio	-	-	-	-	-

Competitive Comparison of Baird Medical Investment Holdings's Total Payout Ratio

For the Medical Devices subindustry, Baird Medical Investment Holdings's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baird Medical Investment Holdings's Total Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's Total Payout Ratio falls into.

Save Embed

;

Save Embed

;

Baird Medical Investment Holdings Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Baird Medical Investment Holdings's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	10.658
	=	0.00

Baird Medical Investment Holdings's Total Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	4.375
	=	0.00

Baird Medical Investment Holdings Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN

Website

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.